CRBP - Corbus Pharmaceuticals Holdings, Inc.
NasdaqCM - NasdaqCM Real-time price. Currency in USD
As of 11:12AM EDT. Market open.
Stock chart is not supported by your current browser
| Previous close | 9.32 |
| Open | 9.32 |
| Bid | 9.10 x 1000 |
| Ask | 9.25 x 3100 |
| Day's range | 9.12 - 9.55 |
| 52-week range | 2.11 - 13.17 |
| Volume | |
| Avg. volume | 439,023 |
| Market cap | 40.829M |
| Beta (5Y monthly) | 2.43 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Corbus Pharmaceuticals (CRBP) Reports Q2 Loss, Lags Revenue Estimates
Corbus Pharmaceuticals (CRBP) delivered earnings and revenue surprises of -16.67% and 100%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
